{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:27Z","timestamp":1790805867202,"version":"4.1.0"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1017\/cjn.2022.278","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:26:10Z","timestamp":1659342370000},"page":"803-805","source":"Crossref","is-referenced-by-count":7,"title":["Managing Myasthenia Gravis with Eculizumab Monotherapy Through Pregnancy"],"prefix":"10.1017","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-3688","authenticated-orcid":false,"given":"Xiaoyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahit","family":"Mehrabyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"S0317167122002785_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1"},{"key":"S0317167122002785_ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000034"},{"key":"S0317167122002785_ref4","first-page":"87","article-title":"Clinical experience with eculizumab in treatment-refractory acetylcholine receptor antibody-positive generalized myasthenia gravis","volume":"8","author":"Katyal","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"S0317167122002785_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211038291"},{"key":"S0317167122002785_ref7","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.916424"},{"key":"S0317167122002785_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0517-z"},{"key":"S0317167122002785_ref3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve"},{"key":"S0317167122002785_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15790"},{"key":"S0317167122002785_ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000511957"},{"key":"S0317167122002785_ref6","unstructured":"6. Alexion Pharmaceuticals, Inc. Soliris(eculizumab) injection; Prescribing information. Revised November 2020. https:\/\/alexion.com\/Documents\/Soliris_USPI.pdf"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167122002785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T05:52:06Z","timestamp":1700891526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167122002785\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0317167122002785"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2022.278","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}